| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |